Skip to main content
. 2018 Jan 22;37:10. doi: 10.1186/s13046-017-0669-z

Table 1.

Correlation of MCM6 protein expression with clinicopathological parameters

Characteristics n MCM6 P value
negative positive
Age (years)
≤ 50 36 7 (19.4%) 29 (80.6%) 0.111
> 50 34 12 (35.3%) 22 (64.7%)
Serum AFP (μg/l)
≤ 20 18 11 (61.1%) 7 (38.9%) 0.000
> 20 52 8 (15.4%) 44 (84.6%)
HBsAg
Negative 8 5 (62.5%) 3 (37.5%) 0.035
Positive 60 15 (25.0%) 45 (75.0%)
GGT (U/I)
≤ 50 28 8 (28.6%) 20 (71.4%) 0.518
> 50 42 11 (26.2%) 31 (73.8%)
Child-Pugh score
A 66 17 (25.8%) 49 (74.2%) 0.603
B 3 1 (33.3%) 2 (66.7%)
Tumor capsule
No/incomplete 61 16 (26.2%) 45 (73.8%) 0.463
Complete 9 3 (33.3%) 6 (66.7%)
Tumor differentiation
I-II 63 16 (25.4%) 47 (74.6%) 0.399
III-IV 5 2 (40.0%) 3 (60.0%)
Vascular invasion
No 63 19 (30.2%) 44 (69.8%) 0.097
Yes 7 0 (0%) 7 (100%)
Liver cirrhosis
No 31 14 (45.2%) 17 (54.8%) 0.003
Yes 39 5 (12.8%) 34 (87.2%)
Tumor size (cm)
≤ 5 34 11 (32.4%) 23 (67.6%) 0.247
> 5 36 8 (22.2%) 28 (77.8%)
Tumor number
Solitary 49 18 (36.7%) 31 (63.3%) 0.004
Multiple 21 1 (4.8%) 20 (95.2%)
Early recurrence
No 36 15 (41.7%) 21 (58.3%) 0.002
Yes 33 3 (9.1%) 30 (90.9%)

(P < 0.05) had been marked in boldface